Aaron Kimball - Mar 1, 2022 Form 4 Insider Report for Zymergen Inc. (ZY)

Signature
/s/ Natalie Dement, attorney-in-fact
Stock symbol
ZY
Transactions as of
Mar 1, 2022
Transactions value $
-$95,345
Form type
4
Date filed
3/3/2022, 05:33 PM
Previous filing
Feb 3, 2022
Next filing
Apr 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZY Common Stock Sale -$95.3K -25K -3.25% $3.81 745K Mar 1, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.
F2 Transaction executed in multiple trades at prices ranging from $3.76 to $3.92 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.